title: Aliskiren reduces portal pressure in cirrhotic rats.
authors: Ching-Chih
authors: CC
authors: Chang
authors: Hui-Chun
authors: HC
authors: Huang
authors: Wen-Shin
authors: WS
authors: Lee
authors: Sun-Sang
authors: SS
authors: Wang
authors: Fa-Yauh
authors: FY
authors: Lee
authors: Han-Chieh
authors: HC
authors: Lin
authors: Jing-Yi
authors: JY
authors: Nong
authors: Shou-Dong
authors: SD
authors: Lee
mesh_terms: D000577:Amides / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001652:Bile Ducts / Q000601:surgery; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight; D005650:Fumarates / Q000494:pharmacology* / Q000627:therapeutic use; D006439:Hemodynamics; D006975:Hypertension, Portal / Q000150:complications* / Q000188:drug therapy*; D008026:Ligation; D008106:Liver Cirrhosis, Experimental / Q000150:complications*; D008297:Male; D052250:Nitric Oxide Synthase Type III / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley; D012084:Renin-Angiotensin System / Q000187:drug effects*
chemical_list: D000577:Amides; D005650:Fumarates; C446481:aliskiren; D052250:Nitric Oxide Synthase Type III